142 related articles for article (PubMed ID: 36749983)
41. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
[TBL] [Abstract][Full Text] [Related]
42. Review of linear and nonlinear models in breath analysis by Cyranose 320.
Arrieta M; Swanson B; Fogg L; Bhushan A
J Breath Res; 2023 May; 17(3):. PubMed ID: 37084720
[TBL] [Abstract][Full Text] [Related]
43. Detection of Barrett's oesophagus through exhaled breath using an electronic nose device.
Peters Y; Schrauwen RWM; Tan AC; Bogers SK; de Jong B; Siersema PD
Gut; 2020 Jul; 69(7):1169-1172. PubMed ID: 32098798
[TBL] [Abstract][Full Text] [Related]
44. Comparative analysis of chemical breath-prints through olfactory technology for the discrimination between SARS-CoV-2 infected patients and controls.
Rodríguez-Aguilar M; Díaz de León-Martínez L; Zamora-Mendoza BN; Comas-García A; Guerra Palomares SE; García-Sepúlveda CA; Alcántara-Quintana LE; Díaz-Barriga F; Flores-Ramírez R
Clin Chim Acta; 2021 Aug; 519():126-132. PubMed ID: 33901429
[TBL] [Abstract][Full Text] [Related]
45. Biomedical detection dogs for the identification of SARS-CoV-2 infections from axillary sweat and breath samples
Devillier P; Gallet C; Salvator H; Lecoq-Julien C; Naline E; Roisse D; Levert C; Breton E; Galtat A; Decourtray S; Prevel L; Grassin-Delyle S; Grandjean D
J Breath Res; 2022 Apr; 16(3):. PubMed ID: 35287115
[TBL] [Abstract][Full Text] [Related]
46. The ovarian cycle may influence the exhaled volatile organic compound profile analyzed by an electronic nose.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Breath Res; 2018 Mar; 12(2):021002. PubMed ID: 29199639
[TBL] [Abstract][Full Text] [Related]
47. Lack of heritability of exhaled volatile compound pattern: an electronic nose twin study.
Tarnoki DL; Bikov A; Tarnoki AD; Lazar Z; Szilagyi BK; Korosi BZ; Horvath T; Littvay L; Losonczy G; Horvath I
J Breath Res; 2014 Mar; 8(1):016001. PubMed ID: 24421262
[TBL] [Abstract][Full Text] [Related]
48. A breath of fresh air - the potential for COVID-19 breath diagnostics.
Davis CE; Schivo M; Kenyon NJ
EBioMedicine; 2021 Jan; 63():103183. PubMed ID: 33418507
[No Abstract] [Full Text] [Related]
49. Detection of COPD and Lung Cancer with electronic nose using ensemble learning methods.
V A B; Subramoniam M; Mathew L
Clin Chim Acta; 2021 Dec; 523():231-238. PubMed ID: 34627826
[TBL] [Abstract][Full Text] [Related]
50. Exhaled breath profiling in patients with COPD and OSA overlap syndrome: a pilot study.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Resta O
J Breath Res; 2016 Nov; 10(4):041001. PubMed ID: 27811380
[TBL] [Abstract][Full Text] [Related]
51. An electronic nose may sniff out amyotrophic lateral sclerosis.
Dragonieri S; Quaranta VN; Carratu P; Ranieri T; Marra L; D'Alba G; Resta O
Respir Physiol Neurobiol; 2016 Oct; 232():22-5. PubMed ID: 27343949
[TBL] [Abstract][Full Text] [Related]
52. Volatile signature for the early diagnosis of lung cancer.
Gasparri R; Santonico M; Valentini C; Sedda G; Borri A; Petrella F; Maisonneuve P; Pennazza G; D'Amico A; Di Natale C; Paolesse R; Spaggiari L
J Breath Res; 2016 Feb; 10(1):016007. PubMed ID: 26857451
[TBL] [Abstract][Full Text] [Related]
53. Pursuing breath research in unprecedented circumstances-report from the Breath Biopsy Conference 2020.
Lawson J; Beauchamp J
J Breath Res; 2021 Jun; 15(3):. PubMed ID: 34107459
[TBL] [Abstract][Full Text] [Related]
54. Diagnosing Non-Small Cell Lung Cancer by Exhaled Breath Profiling Using an Electronic Nose: A Multicenter Validation Study.
Kort S; Brusse-Keizer M; Schouwink H; Citgez E; de Jongh FH; van Putten JWG; van den Borne B; Kastelijn EA; Stolz D; Schuurbiers M; van den Heuvel MM; van Geffen WH; van der Palen J
Chest; 2023 Mar; 163(3):697-706. PubMed ID: 36243060
[TBL] [Abstract][Full Text] [Related]
55. Exhaled VOCs can discriminate subjects with COVID-19 from healthy controls.
Woollam M; Angarita-Rivera P; Siegel AP; Kalra V; Kapoor R; Agarwal M
J Breath Res; 2022 May; 16(3):. PubMed ID: 35453137
[TBL] [Abstract][Full Text] [Related]
56. Breathprinting and Early Diagnosis of Lung Cancer.
Rocco G; Pennazza G; Santonico M; Longo F; Rocco R; Crucitti P; Antonelli Incalzi R
J Thorac Oncol; 2018 Jul; 13(7):883-894. PubMed ID: 29526822
[TBL] [Abstract][Full Text] [Related]
57. An electronic nose in the discrimination of obese patients with and without obstructive sleep apnoea.
Dragonieri S; Porcelli F; Longobardi F; Carratù P; Aliani M; Ventura VA; Tutino M; Quaranta VN; Resta O; de Gennaro G
J Breath Res; 2015 Apr; 9(2):026005. PubMed ID: 25891965
[TBL] [Abstract][Full Text] [Related]
58. Determination of global chemical patterns in exhaled breath for the discrimination of lung damage in postCOVID patients using olfactory technology.
Zamora-Mendoza BN; Sandoval-Flores H; Rodríguez-Aguilar M; Jiménez-González C; Alcántara-Quintana LE; Berumen-Rodríguez AA; Flores-Ramírez R
Talanta; 2023 May; 256():124299. PubMed ID: 36696734
[TBL] [Abstract][Full Text] [Related]
59. Pitfalls in the analysis of volatile breath biomarkers: suggested solutions and SIFT-MS quantification of single metabolites.
Smith D; Spanel P
J Breath Res; 2015 Apr; 9(2):022001. PubMed ID: 25830501
[TBL] [Abstract][Full Text] [Related]
60. Proof of concept for real-time detection of SARS CoV-2 infection with an electronic nose.
Snitz K; Andelman-Gur M; Pinchover L; Weissgross R; Weissbrod A; Mishor E; Zoller R; Linetsky V; Medhanie A; Shushan S; Jaffe E; Sobel N
PLoS One; 2021; 16(6):e0252121. PubMed ID: 34077435
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
